Klinisk Biokemi i Norden Nr 2, vol. 7, 1995 - page 32

with 99mTC-DTPA. Determination of total and
splitrenal function. Kliniskfysiologi,Universitetet
i Göteborg. (940606).
Anders Sjöberg. Growth hormone regulation of
apolipoprotein (APO)-BandAPO-E inculturedrat
hepatocytes.Medicinskochfysiologiskkemi,Uni–
versitetet i Göteborg. (940607).
Jerker Olsson. Mevalonate pathway lipids in
hepatocarcinogenesis. Biokemi, Karolinska insti–
tutet, Stockholm. (940603).
ErikMoberg. Variabilityofbloodglucose levels
and insulin sensitivity in patients with insulin–
dependent diabetes mellitus. Clinical and experi–
mental studies. Medicin, Karolinska institutet,
Stockholm. (940603).
JerkerStigare. Identificationandcharacterization
of a nuclear 42-kDa phosphoprotein with DNA–
binding and protein kinase activities. Cellbiologi,
Karolinska institutet, Stockholm. (940607).
Barbara Norman. IMP accumulation in energy
deficient human skeletal muscle with reference to
substrate availability, fibre types and AMP
deaminase activity. Klinisk fysiologi, Karolinska
institutet, Stockholm. (940603).
Peter Bang. Insulin-like growth factor (IGF)-1
and IGF binding proteins: Serum concentrations,
bioavailability and effects of proteases. Tillväxt–
endokrinologi, Karolinska institutet, Stockholm.
(940607).
Tonis Timmusk. Structure and regulation of
neurotrophinand their low-affinity receptorgenes.
Medicinskbiokemi ochbiofysik,Karolinska insti–
tutet, Stockholm. (940609).
Christina Karlsson. Mammalian sorbitol
dehydrogenase.Medicinskkemi. Karolinska insti–
tutet, Stockholm. (940610).
NHåkan
W
allen. Platelet reactivity and effects
oftreatrnentwithantiischemicorantiplateletdrugs.
Klinisk farmakologi, Karolinska institutet, Stock–
holm. (940613).
SvanteNorgren. Regulation of insulin and insu–
lin receptor gene expression in relation to glucose
homeostasis.Molekylärmedicin, Karolinska insti–
tutet, Stockholm. (940616).
ElinaEriksson.Biologicalmarkers indiagnostic
pathology of benign premalignant and malignant
breastdisease.Patologi,Karolinskainstitutet,Stock–
holm. (940617).
AnetteAsplund-Carlson.Hypertriglyceridaemia.
Clinicalandmetabolicstudies inrandomlyselected
66
men. Medicin, Karolinska institutet, Stockholm.
(940617).
Mats Estonius. Aleobol dehydrogenase. Re–
lationships, distribution and mutagenesis. Kemi,
Karolinska institutet, Stockholm. (940617).
Marie Degerblad. Studies on the GHRH-GH–
IGF axis in pituitary disease with emphasis on
hypercortisolism and pituitary deficiency. Endo–
krinologi, Karolinska instirutet, Stockholm.
(940826).
Graciela Elsa Elgue. Inhibition of the intrinsic
coagulationmechanismby soluteand immobilized
heparin.Kirurgi,Karolinska institutet, Stockholm.
(940909).
EwaEhrenborg. Genetic characterizationofhu–
man insulin-like growth factor binding proteins.
Molekylär medicin, Karolinska institutet, Stock–
holm. (940909).
Eva Särndahl. G-protein - cytoskeleton
interactions in the human neutrophil during
chemoattractantactivation.Mikriobiologi,Univer–
sitetet i Linköping. (940916).
StefanMatthiasson. Lowmolecular weight he–
parin and dextran in thromboprophylaxis. Human
and experimental studies. Kirurgi, Universitetet i
Lund. (940917).
Per-Jonas Blind. Carboxylic ester hydrolase in
the diagnosis of acute pancreatitis. A clinical and
experimental study. Kirurgi,Universitetet iUmeå.
(940928).
Maria Sjöberg. Expression and function of
chieken thyroidhormone receptors.Molekylärbio–
logi, Karolinska institutet, Stockholm. (941
O
14).
Olle Danielsson. Multiplicity and molecular
propertiesofaleobol dehydrogenase. Biokemi och
biofysik, Karolinska institutet, Stockholm.
(941014).
StephanTeglund.Thehumancarcinoembryonic
antigen family-structure, organization and evolu–
tion of the CEA family genes on chromosome
19q13.2. Klinisk mikrobiologi, Universitetet i
Umeå.
Lennart Nilsson. Lipoamidase. Klinisk kemi,
Universitetet i Linköping. (941104).
l
vaEngström. The relationship between energy
economy andmaintenance of ion gradients in hu–
man erythrocytes. Klinisk kemi, Universitetet i
Uppsala. (941124).
Lars Stenberg. Genetics and biochemistry of
group streptococcal cell surfaceproteinswith spe-
KliniskKtmi
i
Norden 2, /995
1...,22,23,24,25,26,27,28,29,30,31 33,34,35,36,37,38,39,40
Powered by FlippingBook